FDA Approves Roche’s Susvimo for Diabetic Retinopathy
Genentech/Roche’s sustained release anti-VEGF eye implant provides a treatment option with reduced frequency for diabetic retinopathy. Sustained release anti-VEGF is…
THE NOT-SO-SWEET LIFE: Trial and tribulations when navigating the bittersweet realities of diabetic retinopathy
Diabetic retinopathy affects millions of people, highlighting the urgent need for education, awareness and early intervention. Technological advancements, including artificial…
latest posts